In breast cancer cell lines, SNAT2 deficiency has been shown to reduce glutamine consumption and cell growth under hypoxia, indicating the importance of SNAT2 in sensitizing cells to oxidative stress (3, 4). Here, SLC38A2 is linked to breast cancer.